Literature DB >> 24378016

Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.

Alicia H Augustine1, Lisa M Lowenstein1, William S Harris2, Gregory C Shearer2, Robert C Block3.   

Abstract

INTRODUCTION: The effects of dietary fatty acid supplementation on lipoprotein fatty acid composition have rarely been described. PATIENTS AND METHODS: Sixty-one overweight and obese adults with dyslipidemia and insulin resistance were randomized to placebo, 2g/day extended-release nicotinic acid (ERN), 4g/day prescription omega-3 fatty acid ethyl ester (P-OM3), or combination therapy for 16 weeks. Lipoprotein fatty acid composition was analyzed by gas chromatography pre- and post-treatment.
RESULTS: Treatment with P-OM3 or combination, but not ERN, increased proportions of eicosapentaenoic acid, docosahexaenoic acid, and docosapentaenoic acid, and reduced those for arachidonic acid in all lipoprotein fractions, with greatest impact in the high-density lipoprotein fraction. P-OM3-induced changes in eicosapentaenoic acid within low-density lipoproteins and very low-density lipoproteins were associated with beneficial effects on mean arterial pressure and pulse pressure.
CONCLUSIONS: P-OM3 supplementation, with or without ERN, was associated with differentially altered lipoprotein fatty acid composition and improved blood pressure parameters.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AA; DHA; EPA; Fish oil; HDL; LA; LDL; Nicotinic acid; VLDL

Mesh:

Substances:

Year:  2013        PMID: 24378016      PMCID: PMC3959884          DOI: 10.1016/j.plefa.2013.12.003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  41 in total

1.  n-3 fatty acids in patients with multiple cardiovascular risk factors.

Authors:  Maria Carla Roncaglioni; Massimo Tombesi; Fausto Avanzini; Simona Barlera; Vittorio Caimi; Paolo Longoni; Irene Marzona; Valentina Milani; Maria Giuseppina Silletta; Gianni Tognoni; Roberto Marchioli
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

2.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

Authors:  Michael Miller; Neil J Stone; Christie Ballantyne; Vera Bittner; Michael H Criqui; Henry N Ginsberg; Anne Carol Goldberg; William James Howard; Marc S Jacobson; Penny M Kris-Etherton; Terry A Lennie; Moshe Levi; Theodore Mazzone; Subramanian Pennathur
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

3.  Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans.

Authors:  William S Harris; James V Pottala; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  J Nutr       Date:  2012-05-23       Impact factor: 4.798

4.  Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region.

Authors:  Rachel R Huxley; Federica Barzi; Tai Hing Lam; Sebastien Czernichow; Xianghua Fang; Tim Welborn; Jonathan Shaw; Hirotsugu Ueshima; Paul Zimmet; Sun Ha Jee; Jeetesh V Patel; Ian Caterson; Vlado Perkovic; Mark Woodward
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

5.  Fish oil -- how does it reduce plasma triglycerides?

Authors:  Gregory C Shearer; Olga V Savinova; William S Harris
Journal:  Biochim Biophys Acta       Date:  2011-10-25

6.  Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men.

Authors:  H D Sesso; M J Stampfer; B Rosner; C H Hennekens; J M Gaziano; J E Manson; R J Glynn
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

7.  Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions.

Authors:  S D Zuijdgeest-van Leeuwen; P C Dagnelie; T Rietveld; J W van den Berg; J H Wilson
Journal:  Br J Nutr       Date:  1999-12       Impact factor: 3.718

8.  Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial.

Authors:  Gregory C Shearer; James V Pottala; Susan N Hansen; Verdayne Brandenburg; William S Harris
Journal:  J Lipid Res       Date:  2012-08-14       Impact factor: 5.922

9.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Authors:  Benjamin F Voight; Gina M Peloso; Marju Orho-Melander; Ruth Frikke-Schmidt; Maja Barbalic; Majken K Jensen; George Hindy; Hilma Hólm; Eric L Ding; Toby Johnson; Heribert Schunkert; Nilesh J Samani; Robert Clarke; Jemma C Hopewell; John F Thompson; Mingyao Li; Gudmar Thorleifsson; Christopher Newton-Cheh; Kiran Musunuru; James P Pirruccello; Danish Saleheen; Li Chen; Alexandre F R Stewart; Arne Schillert; Unnur Thorsteinsdottir; Gudmundur Thorgeirsson; Sonia Anand; James C Engert; Thomas Morgan; John Spertus; Monika Stoll; Klaus Berger; Nicola Martinelli; Domenico Girelli; Pascal P McKeown; Christopher C Patterson; Stephen E Epstein; Joseph Devaney; Mary-Susan Burnett; Vincent Mooser; Samuli Ripatti; Ida Surakka; Markku S Nieminen; Juha Sinisalo; Marja-Liisa Lokki; Markus Perola; Aki Havulinna; Ulf de Faire; Bruna Gigante; Erik Ingelsson; Tanja Zeller; Philipp Wild; Paul I W de Bakker; Olaf H Klungel; Anke-Hilse Maitland-van der Zee; Bas J M Peters; Anthonius de Boer; Diederick E Grobbee; Pieter W Kamphuisen; Vera H M Deneer; Clara C Elbers; N Charlotte Onland-Moret; Marten H Hofker; Cisca Wijmenga; W M Monique Verschuren; Jolanda M A Boer; Yvonne T van der Schouw; Asif Rasheed; Philippe Frossard; Serkalem Demissie; Cristen Willer; Ron Do; Jose M Ordovas; Gonçalo R Abecasis; Michael Boehnke; Karen L Mohlke; Mark J Daly; Candace Guiducci; Noël P Burtt; Aarti Surti; Elena Gonzalez; Shaun Purcell; Stacey Gabriel; Jaume Marrugat; John Peden; Jeanette Erdmann; Patrick Diemert; Christina Willenborg; Inke R König; Marcus Fischer; Christian Hengstenberg; Andreas Ziegler; Ian Buysschaert; Diether Lambrechts; Frans Van de Werf; Keith A Fox; Nour Eddine El Mokhtari; Diana Rubin; Jürgen Schrezenmeir; Stefan Schreiber; Arne Schäfer; John Danesh; Stefan Blankenberg; Robert Roberts; Ruth McPherson; Hugh Watkins; Alistair S Hall; Kim Overvad; Eric Rimm; Eric Boerwinkle; Anne Tybjaerg-Hansen; L Adrienne Cupples; Muredach P Reilly; Olle Melander; Pier M Mannucci; Diego Ardissino; David Siscovick; Roberto Elosua; Kari Stefansson; Christopher J O'Donnell; Veikko Salomaa; Daniel J Rader; Leena Peltonen; Stephen M Schwartz; David Altshuler; Sekar Kathiresan
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

10.  Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein.

Authors:  Maryam Boshtam; Amirnader Emami Razavi; Morteza Pourfarzam; Mohsen Ani; Gholam Ali Naderi; Gholam Basati; Marjan Mansourian; Narges Jafari Dinani; Seddigheh Asgary; Soheila Abdi
Journal:  Dis Markers       Date:  2013-09-12       Impact factor: 3.434

View more
  6 in total

Review 1.  ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

Authors:  Timothy D O'Connell; Robert C Block; Shue P Huang; Gregory C Shearer
Journal:  J Mol Cell Cardiol       Date:  2016-12-14       Impact factor: 5.000

2.  Unsaturated Fatty Acids Improve Atherosclerosis Markers in Obese and Overweight Non-diabetic Elderly Patients.

Authors:  Patrícia Amante de Oliveira; Cristiane Kovacs; Priscila Moreira; Daniel Magnoni; Mohamed Hassan Saleh; Joel Faintuch
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

Review 3.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

Review 4.  Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

Authors:  Annabelle Rodriguez; Bernardo L Trigatti; Chieko Mineo; Darcy Knaack; John T Wilkins; Daisy Sahoo; Bela F Asztalos; Samia Mora; Marina Cuchel; Henry J Pownall; Corina Rosales; Pascal Bernatchez; Amanda Ribeiro Martins da Silva; Godfrey S Getz; Jacob L Barber; Gregory C Shearer; Angela M Zivkovic; Uwe J F Tietge; Frank M Sacks; Margery A Connelly; Michael N Oda; W Sean Davidson; Mary G Sorci-Thomas; Tomas Vaisar; Giacomo Ruotolo; Kasey C Vickers; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-10       Impact factor: 8.311

5.  Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial.

Authors:  Flávia De Conti Cartolano; Gabriela Duarte Dias; Sayuri Miyamoto; Nágila Raquel Teixeira Damasceno
Journal:  Front Nutr       Date:  2022-02-23

6.  Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor.

Authors:  Marcella Neves Dátilo; Marcella Ramos Sant'Ana; Guilherme Pedron Formigari; Patrícia Brito Rodrigues; Leandro Pereira de Moura; Adelino Sanchez Ramos da Silva; Eduardo Rochete Ropelle; José Rodrigo Pauli; Dennys Esper Cintra
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.